Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Pratik Pimple"'
Autor:
Pratik Pimple, Bruno B. Lima, Muhammad Hammadah, Kobina Wilmot, Ronnie Ramadan, Oleksiy Levantsevych, Samaah Sullivan, Jeong Hwan Kim, Belal Kaseer, Amit J. Shah, Laura Ward, Paolo Raggi, J. Douglas Bremner, John Hanfelt, Tene Lewis, Arshed A. Quyyumi, Viola Vaccarino
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 9 (2019)
Background Higher symptom levels of a variety of measures of emotional distress have been associated with cardiovascular disease (CVD), especially among women. Here, our goal was to investigate the association between a composite measure of psycholog
Externí odkaz:
https://doaj.org/article/94c6f7704ed841fa97e4e77b5f7f1447
Sex Differences in Mental Stress‐Induced Myocardial Ischemia in Patients With Coronary Heart Disease
Autor:
Viola Vaccarino, Kobina Wilmot, Ibhar Al Mheid, Ronnie Ramadan, Pratik Pimple, Amit J. Shah, Ernest V. Garcia, Jonathon Nye, Laura Ward, Muhammad Hammadah, Michael Kutner, Qi Long, J. Douglas Bremner, Fabio Esteves, Paolo Raggi, Arshed A. Quyyumi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 9, Pp n/a-n/a (2016)
Background Emerging data suggest that young women with coronary heart disease (CHD) are disproportionally vulnerable to the adverse cardiovascular effects of psychological stress. We hypothesized that younger, but not older, women with stable CHD are
Externí odkaz:
https://doaj.org/article/d859645d993249d3a41919d7fe781dce
Autor:
Jingkai Wei, Pratik Pimple, Amit J Shah, Cherie Rooks, J Douglas Bremner, Jonathon A Nye, Ijeoma Ibeanu, Nancy Murrah, Lucy Shallenberger, Paolo Raggi, Viola Vaccarino
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102986 (2014)
Depression is an adverse prognostic factor after an acute myocardial infarction (MI), and an increased propensity toward emotionally-driven myocardial ischemia may play a role. We aimed to examine the association between depressive symptoms and menta
Externí odkaz:
https://doaj.org/article/a4254af10295448ca121a98e82160860
Autor:
Samuel K Peasah, Yan Huang, Swetha R Palli, Elizabeth CS Swart, Bonnie MK Donato, Pratik Pimple, Jacqueline Bovier, Chronis Manolis, Chester B Good
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:152-160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30b24cd87754c0358784deef7ff93db3
https://doi.org/10.18553/jmcp.2023.29.2.152
https://doi.org/10.18553/jmcp.2023.29.2.152
Autor:
Vinay Chiguluri, Raymond A. Harvey, Michael W. Kattan, Todd Prewitt, Pratik Pimple, Eleanor O. Caplan, Ashley Goss, Jennifer Hayden, Rakesh Luthra
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:1579-1591
BACKGROUND: Cardiovascular (CV) risk tools have been developed both nationally and internationally to identify patients at risk for developing CV disease or experiencing a CV event. However, these tools vary widely in the definitions of endpoints, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e16fa8ec6ba40f0e4e1f25d23b53c498
https://doi.org/10.18553/jmcp.2021.27.11.1579
https://doi.org/10.18553/jmcp.2021.27.11.1579
Autor:
Sarah Brand, Sharash Shetty, Odette Reifsnider, Anuraag R. Kansal, Valerie Aponte-Ribero, Pratik Pimple
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To estimate the cost‐effectiveness of sequential addition of empagliflozin versus sitagliptin after metformin in patients with type 2 diabetes (T2D) with or without cardiovascular disease (CVD) from the perspective of the US healthcare payer. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1efffcd6ff7002ebdb15448a19685ed2
https://doi.org/10.1111/dom.14268
https://doi.org/10.1111/dom.14268
Publikováno v:
Journal of managed carespecialty pharmacy. 28(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2fcfb58f26fd86ea02fc1334fb8a23
https://pubmed.ncbi.nlm.nih.gov/35098748
https://pubmed.ncbi.nlm.nih.gov/35098748
Autor:
Odette S. Reifsnider, Pratik Pimple, Sarah Brand, Evelien Bergrath Washington, Sharash Shetty, Nihar R. Desai
Publikováno v:
Diabetes, obesitymetabolism. 24(4)
To estimate the cost-effectiveness of sequential use of the sodium-glucose co-transporter-2 inhibitor empagliflozin and glucagon-like peptide-1 receptor agonist liraglutide after metformin in patients with type 2 diabetes (T2D) from the US payer pers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d368ac4c02b80557b7f6ab164a747d04
https://pubmed.ncbi.nlm.nih.gov/34910356
https://pubmed.ncbi.nlm.nih.gov/34910356
Autor:
null Odette S. Reifsnider, null Pratik Pimple, null Sarah Brand, null Evelien Bergrath Washington, null Sharash Shetty, null Nihar R. Desai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8a2c5948c975b30090d8c366a397c5d
https://doi.org/10.1111/dom.14625/v2/response1
https://doi.org/10.1111/dom.14625/v2/response1
Publikováno v:
Diabetes Therapy
Introduction Empagliflozin has demonstrated lower rates of cardiovascular outcomes vs. standard of care among patients with type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). However, the impact of empagliflozin compared to other brand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fdd8384a332f77398d1bd16d0a62bba
https://pubmed.ncbi.nlm.nih.gov/34727356
https://pubmed.ncbi.nlm.nih.gov/34727356